Cara Therapeutics | CARA - Interest Income

Stock Price
3.64
Daily Change
0.05 1.39%
Monthly
-22.55%
Yearly
-75.59%
Q1 Forecast
3.53

Cara Therapeutics reported $347K in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Chugai Pharma JPY 480M 465M Jun/2024
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
J&J USD 2.12 0.17 Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025